AAO 2024: New gene therapy shows promise for treatment of …
Oct 20, 2024 · New research unveiled today at the 128th annual meeting of the American Academy of Ophthalmology in Chicago reveals that a novel gene therapy may improve vision …
Ophthalmology Times - Ophthalmology news, articles, and events
A team of researchers in China detail a case of Thelazia callipaeda infection in the right eye of a 41-year-old woman working in an office. The patient presented with persistent foreign body …
Johnson & Johnson launches TECNIS Odyssey IOL in US
Oct 1, 2024 · Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.. The TECNIS Odyssey IOL is a new full vision range …
AAO 2024: Long-term low-dose antiviral treatment benefits …
Oct 19, 2024 · Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles …
FDA accepts NDA from Aldeyra Therapeutics for reproxalap for dry …
Nov 19, 2024 · The FDA has accepted the resubmitted new drug application (NDA) from Aldeyra Therapeutics for its first-in-class investigational candidate, topical ocular reproxalap for the …
ASCRS 2024: What advancements in Light Adjustable Lens …
Apr 10, 2024 · Neda Nikpoor, MD, spoke to Ophthalmology Times about her presentation on the Light Adjustable Lens during an ASCRS symposia on IOL calculations.. Video Transcript. …
AAO 2024: Clinical updates on Neurotech's NT-501
Oct 18, 2024 · Thomas Aaberg Jr, MD sat down to discuss previous presentations by Neurotech at EURETINA and Retina Society as well as upcoming presentations on NT-501 at this year's …
Expanding the range of vision with monofocal IOLs
Sep 17, 2024 · Reviewed by Kamran M. Riaz, MD. During a recent Ophthalmology Times Case-Based Roundtable, Kamran M. Riaz, MD, discussed expanding the use of enhanced …
AAO 2024: Livionex reports positive end-of-phase 2 meeting with …
Oct 18, 2024 · According to the company, there are no FDA-approved pharmacological therapies for age-related cataracts. Its C-KAD eye drop, improves vision in patients with early-to …
Physicians sort out pros and cons of several new IOLs on the market
Nov 12, 2021 · Monofocal IOLs The monofocal category was expanded recently with 2 novel aspheric hydrophobic acrylic lenses—the TECNIS Eyhance (ICB00, Johnson + Johnson …